[Clinical and immunologic effect of likopid in complex therapy of occupational bronchial asthma].
Use of immune modulators for occupational bronchial asthma is expedient pathogenetically. Therefore the authors evaluated efficiency of LICOPID made in Russia for treatment of occupational bronchial asthma caused by chemical hazards and complicated by infection.
Tarasova
O V
OV
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D008875:Middle Aged; D009784:Occupational Diseases / Q000188:drug therapy* / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology
D000276:Adjuvants, Immunologic; D007073:Immunoglobulin E; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C023868:N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine
Kliniko-immunologicheskie éffekty likopida v kompleksnoĭ terapii bol'nykh professional'noĭ astmoĭ.